Does TOFACITINIB Cause Unevaluable event? 154 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 154 reports of Unevaluable event have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.1% of all adverse event reports for TOFACITINIB.
154
Reports of Unevaluable event with TOFACITINIB
0.1%
of all TOFACITINIB reports
0
Deaths
24
Hospitalizations
How Dangerous Is Unevaluable event From TOFACITINIB?
Of the 154 reports, 24 (15.6%) required hospitalization, and 1 (0.6%) were considered life-threatening.
Is Unevaluable event Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 154 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Unevaluable event?
ADALIMUMAB (4,242)
ETANERCEPT (3,902)
LENALIDOMIDE (3,331)
OXYCODONE (3,145)
AMBRISENTAN (2,336)
SODIUM OXYBATE (2,328)
CARBIDOPA\LEVODOPA (1,632)
DUPILUMAB (1,410)
MORPHINE (1,161)
ACETAMINOPHEN\HYDROCODONE (1,118)
Which TOFACITINIB Alternatives Have Lower Unevaluable event Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN